Drug Shortage Report for EPHEDRINE SULFATE INJECTION USP

Last updated on 2019-03-30 History
Report ID 1218
Drug Identification Number 00038121
Brand name EPHEDRINE SULFATE INJECTION
Common or Proper name Ephedrine
Company Name PFIZER CANADA ULC
Market Status CANCELLED POST MARKET
Active Ingredient(s) EPHEDRINE SULFATE
Strength(s) 50MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR SUBCUTANEOUS
Packaging size 50mg/1mL x 50
ATC code R03CA
ATC description ADRENERGICS FOR SYSTEMIC USE
Reason for shortage Shortage of an active ingredient.
Anticipated start date
Actual start date 2015-07-24
Estimated end date
Actual end date 2019-03-29
Shortage status Resolved
Updated date 2019-03-30
Company comments Product is discontinued
Health Canada comments
Tier 3 Status No
Contact Address 17300 TRANS-CANADA HIGHWAY
KIRKLAND, QUEBEC
CANADA H9J 2M5
Company contact information Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v7 2019-03-30 English Compare
v6 2019-03-29 French Compare
v5 2019-03-29 English Compare
v4 2017-03-14 French Compare
v3 2017-03-14 English Compare
v2 2017-03-13 French Compare
v1 2017-03-13 English Compare

Showing 1 to 7 of 7